聚 L-赖氨酸盐酸盐结构式
|
常用名 | 聚 L-赖氨酸盐酸盐 | 英文名 | Poly-L-lysine hydrochloride |
---|---|---|---|---|
CAS号 | 26124-78-7 | 分子量 | N/A | |
密度 | N/A | 沸点 | N/A | |
分子式 | (C6H14N2O2)x.(HCl)x | 熔点 | N/A | |
MSDS | 美版 | 闪点 | N/A |
聚 L-赖氨酸盐酸盐用途Poly-L-lysine hydrochloride 是一种非特异性的细胞附着因子,通过增强细胞膜负离子与培养基表面的静电相互作用,促进细胞对固体基质的粘附。Poly-L-lysine 是一种抗菌肽。Poly-L-lysine 低浓度促进相分离 (Liquid-liquid phase separation,LLPS),高浓度抑制相分离。 |
中文名 | 聚 L-赖氨酸盐酸盐 |
---|---|
英文名 | POLY-L-LYSINE HYDROCHLORIDE |
英文别名 | 更多 |
描述 | Poly-L-lysine hydrochloride 是一种非特异性的细胞附着因子,通过增强细胞膜负离子与培养基表面的静电相互作用,促进细胞对固体基质的粘附。Poly-L-lysine 是一种抗菌肽。Poly-L-lysine 低浓度促进相分离 (Liquid-liquid phase separation,LLPS),高浓度抑制相分离。 |
---|---|
相关类别 | |
体外研究 | 聚赖氨酸是一种与蛋白质形成复合物的食品级抗菌肽。这种复合物是靶向给药的潜在载体。用静电势模型描述了EPL的相互作用亲和力。建立了三维相界曲线,将络合分为纳米级和相分离两个阶段[2]。 |
参考文献 |
分子式 | (C6H14N2O2)x.(HCl)x |
---|---|
储存条件 | −20°C |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links
Biomaterials 33 , 1489-1499, (2012) A robust core-shell-corona micelle bearing redox-responsive shell-specific cross-links was evaluated as a carrier of docetaxel (DTX) for cancer therapy. The polymer micelles of poly(ethylene glycol)- ... |
|
Improving covalent cell encapsulation with temporarily reactive polyelectrolytes.
J. Mater. Sci. Mater. Med. 23(1) , 181-93, (2011) Calcium alginate/poly-L-lysine beads were coated with either 50% hydrolyzed poly(methyl vinyl ether-alt-maleic anhydride) (PMM(50)), or with poly(vinyl dimethyl azlactone-co-methacrylic acid) (50:50, ... |
|
Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine.
Biomaterials 33(7) , 2361-71, (2011) Highly compacted DNA nanoparticles, composed of single molecules of plasmid DNA compacted with block copolymers of polyethylene glycol and poly-L-lysine (PEG-CK(30)), have shown considerable promise i... |
MFCD00081870 |